"Repaglinide (0.5mg), Voglibose (0.3mg): Control Blood Sugar"

RAPIGLINIDE VOG 0.5 

Repaglinide (0.5mg), Voglibose (0.3mg)

Introduction

Repaglinide (0.5mg) and Voglibose (0.3mg) is a combination medication designed to manage type 2 diabetes mellitus. By combining the effects of a meglitinide and an alpha-glucosidase inhibitor, this medication helps control blood sugar levels more effectively, particularly after meals.

Uses of Repaglinide (0.5mg), Voglibose (0.3mg)

1. Type 2 Diabetes Management: This combination is used to improve blood sugar control in adults with type 2 diabetes.
2. Postprandial Glucose Regulation: It helps manage blood sugar levels after meals, reducing postprandial hyperglycemia.
3. Preventing Complications: Effective blood sugar management with this combination reduces the risk of complications such as heart disease, kidney damage, and nerve problems.

How Repaglinide (0.5mg), Voglibose (0.3mg) Works

• Repaglinide: A meglitinide that stimulates the pancreas to release insulin, helping to lower blood sugar levels after meals.
• Voglibose: An alpha-glucosidase inhibitor that slows down the breakdown of carbohydrates in the intestines, reducing the rise in blood sugar levels after eating.

Dosage and Administration

Repaglinide (0.5mg), Voglibose (0.3mg) is typically taken before meals, usually two to three times daily. It is crucial to follow your doctor’s instructions regarding dosage and timing. Regular monitoring of blood sugar levels is essential to ensure the medication is working effectively.

Side Effects

Common side effects include gastrointestinal issues such as diarrhea, abdominal pain, and flatulence. Other side effects can include hypoglycemia (low blood sugar), headache, and dizziness. Serious side effects, although rare, can include severe hypoglycemia and allergic reactions. If you experience any severe or unusual symptoms, contact your healthcare provider immediately.

Precautions

• Medical History: Inform your doctor if you have a history of liver or kidney problems, gastrointestinal disorders, or other medical conditions.
• Drug Interactions: This medication can interact with other drugs, such as insulin and other oral antidiabetics. Provide your healthcare provider with a complete list of your medications.
• Pregnancy and Breastfeeding: Consult your doctor if you are pregnant or breastfeeding before starting this medication.

Conclusion

Repaglinide (0.5mg), Voglibose (0.3mg) is a highly effective combination for managing type 2 diabetes. With proper use and regular medical supervision, patients can achieve significant improvements in their blood sugar control and overall quality of life.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW